Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of TV-45070 Ointment in Healthy Subjects
NCT02215941Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of funapide in neuropathic pain, postherpetic neuralgia (PHN) and erythromelalgia (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Plasma concentrations of TV-45070 at Day 8. Started Aug 2014; status: completed.
02
Drugs
funapide
03
Conditions
neuropathic painpostherpetic neuralgia (PHN)erythromelalgia
Beyond the preview
Go deeper on NCT02215941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215941.